Salarius Pharmaceuticals, Inc.

Salarius Pharmaceuticals, Inc.verified

SLRX

Price:

$1.48

Market Cap:

$2.13M

Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer treatments. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers SP-3164, a small molecular protein degrader for the treatment of hematological and solid tumors. It has a strategic partnership with The University of Utah Research Foundation for the exclusive license with respect to patent rights protecting SP-2577 and related compounds; HLB Life Sciences to develop, produce, manufacture, use, and sell the drug in South Korea;...[Read more]

Industry

Biotechnology

IPO Date

2015-01-29

Stock Exchange

NASDAQ

Ticker

SLRX

The Dividend Yield as of November 2024 (TTM) for Salarius Pharmaceuticals, Inc. (SLRX) is 0%

According to Salarius Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Salarius Pharmaceuticals, Inc. (SLRX) Historical Dividend Yield (quarterly & annually)

How has SLRX Dividend Yield performed in the past?

The mean historical Dividend Yield of Salarius Pharmaceuticals, Inc. over the last ten years is 0.01%. The current 0% Dividend Yield has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), SLRX's Dividend Yield was at its highest in in the December 2019 quarter at 0.14%. The Dividend Yield was at its lowest in in the September 2014 quarter at 0%.

Quarterly (TTM)
Annual

Average

0.01%

Median

0%

Minimum

0%

Maximum

0.14%

Salarius Pharmaceuticals, Inc. (SLRX) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Salarius Pharmaceuticals, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Dividend Yield = 0.14%

Minimum Annual Increase = 0%

Minimum Annual Dividend Yield = 0%

Quarterly (TTM)
Annual
YearDividend YieldChange
20230%0%
20220%0%
20210%0%
20200%-100.00%
20190.14%Infinity%
20180%0%
20170%0%
20160%0%
20150%0%

Salarius Pharmaceuticals, Inc. (SLRX) Average Dividend Yield

How has SLRX Dividend Yield performed in the past?

The current Dividend Yield of Salarius Pharmaceuticals, Inc. (SLRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0%

5-year avg

0.03%

10-year avg

0.01%

Salarius Pharmaceuticals, Inc. (SLRX) Dividend Yield vs. Peers

How is SLRX’s Dividend Yield compared to its peers?

Salarius Pharmaceuticals, Inc.’s Dividend Yield is less than Akari Therapeutics, Plc (0%), less than Axcella Health Inc. (0%), less than Magenta Therapeutics, Inc. (0%), less than Histogen Inc. (0%), less than Timber Pharmaceuticals, Inc. (0%), less than Artelo Biosciences, Inc. (0%), less than Nutriband Inc. (0%), less than Aileron Therapeutics, Inc. (0%), less than First Wave BioPharma, Inc. (0%), less than SAB Biotherapeutics, Inc. (0%), less than Vaccinex, Inc. (0%), less than GeoVax Labs, Inc. (0%), less than Corvus Pharmaceuticals, Inc. (0%), less than Mereo BioPharma Group plc (0%), less than Affimed N.V. (0%), less than Pieris Pharmaceuticals, Inc. (0%), less than Artelo Biosciences, Inc. (0%), less than Fresh Tracks Therapeutics, Inc. (0%),

Build a custom stock screener for Salarius Pharmaceuticals, Inc. (SLRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Salarius Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Salarius Pharmaceuticals, Inc. (SLRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Salarius Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Dividend Yield?

How can you use the Dividend Yield?

What is Salarius Pharmaceuticals, Inc.'s Dividend Yield?

How is the Dividend Yield calculated for Salarius Pharmaceuticals, Inc. (SLRX)?

What is the highest Dividend Yield for Salarius Pharmaceuticals, Inc. (SLRX)?

What is the 3-year average Dividend Yield for Salarius Pharmaceuticals, Inc. (SLRX)?

What is the 5-year average Dividend Yield for Salarius Pharmaceuticals, Inc. (SLRX)?

How does the current Dividend Yield for Salarius Pharmaceuticals, Inc. (SLRX) compare to its historical average?